I am Muqddas Tariq, currently working as a postdoctoral fellow in the Ronald O. Perelman Department of Dermatology, NYU Langone Medical Center since October 2023. I am from Pakistan and obtained my Ph.D. from the Guangzhou Institutes of Biomedicine & Health (GIBH), Chinese Academy of Sciences (CAS), majoring in Cell Biology. As part of my Ph.D. projects, I worked in the area of stem cell and regenerative biology and acquired the necessary skill set relevant to cell/molecular biology, RNA binding protein interactome analysis, and epitranscriptome modifications. Until now, I have contributed to 17 publications (including research and review articles), 10 of which emerged during my Ph.D. tenure at GIBH.  During my doctoral study, I have been working on a project that led to the development of a new methodology, named RICK (RNA Interactome capture using ClicK chemistry), for systemic capturing of the newly transcribed RNA binding proteins (RBPs) in cancer and mESCs. The working principle of this methodology is based upon the incorporation of 5-ethynyluridine (EU) into newly transcribed RNAs followed by click chemistry. Parts of the work were later published in ***Nature Methods ***2018 (my credit as a 2nd author) and ***Nature Protocols*** 2021 (my credit as a co-first author). Apart from establishing the RICK methodology, I generated three induced pluripotent stem cells (iPSCs) lines from a Parkinson’s disease patient with mutant *PARKIN*. Part of this work was then published in ***Stem Cell Research*** 2020. Moreover, I also worked on a project aimed at identifying N6-methyladenosine (m6A)-based mRNA binding exclusive RBPs *in vivo* using *Mettl3* KO and WT mESCs. My efforts led to defining an m6A interactome (containing some novel binders and repellants) that was not identified previously. This work was still in progress when I left the lab in my capacity as an “Associate researcher” (the position I got hired for after my graduation in 2020 during the COVID-19 surge in China).